IBIO INC (IBIO) Stock Analyst Ratings
NASDAQ:IBIO - Nasdaq - US4510337086 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to IBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.96. This target is 513.9% above the current price.
IBIO was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IBIO.
In the previous month the buy percentage consensus was at a similar level.
IBIO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-17 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2024-07-22 | Brookline Capital | Initiate | Buy |
| 2024-06-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-28 | Chardan Capital | Initiate | Buy |
| 2023-02-16 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-10-07 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2021-11-29 | JMP Securities | Initiate | Outperform |